Using the same cell capsules in a double transgenic mouse model of Alzheimer's disease, we found a significant anti-inflammatory effect with GLP-1 engineered MSCs, but not with MSC without GLP-1 secretion [15]. The gene discussed is GLP1R; the disease is early-onset autosomal dominant Alzheimer disease.